Albuterol
Treatment for Asthma
Typical Dosage: 2 puffs every 4-6 hours as needed
Effectiveness
92%
Safety Score
50%
Clinical Trials
475
Participants
50K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
50
DangerousModerateSafe
Treatment Details
Dosage Range
2 puffs every 4-6 hours as needed
Time to Effect
immediate
Treatment Duration
as needed
Evidence Quality
HIGHNumber Needed to Treat (NNT)
2(Treat 2 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
1000(Treat 1000 patients to see 1 additional serious adverse event)
Confidence Score
98%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$150
Monitoring:$50
Side Effect Mgmt:$20
Total Annual:$220
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0
Outcome-Based Costs
Cost per Responder
$239
Albuterol Outcomes
for Asthma
Efficacy Outcomes
Overall Effectiveness
+92%
Response Rate
+92%
Common Side Effects
Tremor
+15%
Tachycardia/Palpitations
+10%
Headache
+8%
Sources:
Active Clinical Trials
1 active trial recruiting for Albuterol in Asthma
Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild Asthma
NCT06563102ACTIVE NOT RECRUITINGPHASE4
101 participants
INTERVENTIONAL
Phoenix, United States +15 more
Started: Sep 11, 2024
Completed Clinical Trials
16 completed trials for Albuterol in Asthma
Albuterol Versus Xopenex in Treatment of Acute Asthma in the Emergency Department (ED)
NCT00585039COMPLETEDPHASE4
101 participants
INTERVENTIONAL
Phoenix, United States
Started: Sep 1, 2005
Teva Asthma Predictive Analytics Study
NCT04997304COMPLETEDPHASE4
100 participants
INTERVENTIONAL
Ann Arbor, United States
Started: Jul 9, 2021
Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients
NCT01899144COMPLETEDPHASE2
61 participants
INTERVENTIONAL
Birmingham, United States +21 more
Started: Jul 1, 2013
Evaluation of Pharmacokinetics and Safety of A006 in Healthy Volunteers
NCT02271334COMPLETEDPHASE2
22 participants
INTERVENTIONAL
Cypress, United States
Started: Aug 1, 2014
Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma
NCT03371459COMPLETEDPHASE2
46 participants
INTERVENTIONAL
Winter Park, United States +4 more
Started: Dec 29, 2017
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
NCT02210806COMPLETEDPHASE2
22 participants
INTERVENTIONAL
San Jose, United States +3 more
Started: Jul 1, 2014
Study of Levalbuterol, Racemic Albuterol and Placebo in Subjects Twelve Years of Age and Older With Asthma
NCT00073840COMPLETEDPHASE3
386 participants
INTERVENTIONAL
Oxford, United States +53 more
Started: Dec 1, 2002
Pharmacokinetic and Pharmacodynamic Profiles of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric Patients With Asthma
NCT01844401COMPLETEDPHASE1
15 participants
INTERVENTIONAL
Costa Mesa, United States
Started: Apr 1, 2013
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
NCT06154304COMPLETEDPHASE3
120 participants
INTERVENTIONAL
Medford, United States
Started: Dec 6, 2023
Albuterol HFA MDI in Pediatric Participants With Asthma
NCT00577655COMPLETEDPHASE3
103 participants
INTERVENTIONAL
Huntington Beach, United States +12 more
Started: Aug 1, 2007
Study to Compare PT007 to Placebo MDI and Open-Label Proventil® HFA in Adult and Adolescent Subjects With Asthma
NCT03364608COMPLETEDPHASE2
86 participants
INTERVENTIONAL
Rolling Hills Estates, United States +9 more
Started: Dec 15, 2017
Continuous Levalbuterol for Treatment of Status Asthmaticus in Children
NCT00124176COMPLETEDPHASE4
81 participants
INTERVENTIONAL
Philadelphia, United States
Started: Apr 1, 2004
A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma Patients
NCT01076322COMPLETEDPHASE3
17 participants
INTERVENTIONAL
Taipei, Taiwan
Started: Mar 1, 2009
Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma
NCT02624505COMPLETEDPHASE3
110 participants
INTERVENTIONAL
Denver, United States
Started: Dec 1, 2015
A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma
NCT00809757COMPLETEDPHASE3
197 participants
INTERVENTIONAL
Little Rock, United States +45 more
Started: Dec 1, 2008
Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma
NCT00684866COMPLETEDPHASE2
31 participants
INTERVENTIONAL
Madera, United States +10 more
Started: Jan 1, 2003
Showing 20 of 475 total trials